Pharmaceutical ingredient manufacturer Cambrex has taken a majority stake in Indian formulator Zenara Pharma for $20 million in a move …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

